Control of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1

The mechanisms by which quiescent cells, including adult stem cells, preserve their ability to resume proliferation after weeks or even years of cell cycle arrest are not known. We report that reversibility is not a passive property of nondividing cells, because enforced cell cycle arrest for a period as brief as 4 days initiates spontaneous, premature, and irreversible senescence. Increased expression of the gene encoding the basic helix-loop-helix protein HES1 was required for quiescence to be reversible, because HES1 prevented both premature senescence and inappropriate differentiation in quiescent fibroblasts. In some human tumors, the HES1 pathway was activated, which allowed these cells to evade differentiation and irreversible cell cycle arrest. We conclude that HES1 safeguards against irreversible cell cycle exit both during normal cellular quiescence and pathologically in the setting of tumorigenesis.

[1]  D. Stearns,et al.  Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. , 2006, Cancer research.

[2]  Masashi Narita,et al.  Reversal of human cellular senescence: roles of the p53 and p16 pathways , 2003, The EMBO journal.

[3]  S. Tapscott,et al.  Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. , 1993, Science.

[4]  M. McDermott,et al.  Meningioma transcript profiles reveal deregulated Notch signaling pathway. , 2005, Cancer research.

[5]  S. Bray,et al.  The Notch signalling pathway is required for Enhancer of split bHLH protein expression during neurogenesis in the Drosophila embryo. , 1994, Development.

[6]  S. Heimfeld,et al.  HES1 Inhibits Cycling of Hematopoietic Progenitor Cells via DNA Binding , 2006, Stem cells.

[7]  C. Sapienza,et al.  A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting , 1989 .

[8]  L. L. Reed,et al.  Notch-independent regulation of Hes-1 expression by c-Jun N-terminal kinase signaling in human endothelial cells , 2006, Laboratory Investigation.

[9]  J. Campisi,et al.  Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.

[10]  James M. Roberts,et al.  Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.

[11]  C. Haass,et al.  A γ‐secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish , 2002, EMBO reports.

[12]  James M. Roberts,et al.  A New Description of Cellular Quiescence , 2006, PLoS biology.

[13]  Christel Brou,et al.  Signalling downstream of activated mammalian Notch , 1995, Nature.

[14]  R. Shigemoto,et al.  Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. , 1992, Genes & development.

[15]  J. Fernández,et al.  A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. , 1999, Genes & development.

[16]  Alfred L. Fisher,et al.  The WRPW motif of the hairy-related basic helix-loop-helix repressor proteins acts as a 4-amino-acid transcription repression and protein-protein interaction domain , 1996, Molecular and cellular biology.

[17]  A. Tyner,et al.  p21 Functions to Maintain Quiescence of p27-deficient Hepatocytes* , 2002, The Journal of Biological Chemistry.

[18]  J. Ashby.  References and Notes , 1999 .

[19]  Joel I. Pritchard,et al.  The SmoA1 Mouse Model Reveals That Notch Signaling Is Critical for the Growth and Survival of Sonic Hedgehog-Induced Medulloblastomas , 2004, Cancer Research.

[20]  M. Fey,et al.  The Notch pathway in ovarian carcinomas and adenomas , 2005, British Journal of Cancer.

[21]  S. Lowe,et al.  Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence , 2003, Cell.

[22]  S. Grigoryev,et al.  The end adjusts the means: Heterochromatin remodelling during terminal cell differentiation , 2006, Chromosome Research.

[23]  D. Scadden,et al.  Hematopoietic stem cell quiescence maintained by p21cip1/waf1. , 2000, Science.

[24]  T. Dang,et al.  Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. , 2007, Cancer research.

[25]  G. Hannon,et al.  Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.

[26]  N. Anderson,et al.  Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. , 2007, Journal of the National Cancer Institute.

[27]  S. Stifani,et al.  Molecular interaction between TLE1 and the carboxyl-terminal domain of HES-1 containing the WRPW motif. , 1996, Biochemical and biophysical research communications.

[28]  K. Walsh,et al.  MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation , 1995, Molecular and cellular biology.

[29]  K. McCue,et al.  Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling , 2008, Oncogene.

[30]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.